David Amess – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by David Amess on 2016-01-07.

To ask the Secretary of State for Health, what proportion of medicines selected by NHS England Clinical Reference Groups for the development of commissioning policies have been (a) approved and (b) not approved by each Programme of Care board.

George Freeman

National Programmes of Care boards do not approve or decline proposed investments in specialised services.

Decisions on proposed investments are made by NHS England’s Specialised Commissioning Oversight Group and the Specialised Commissioning Committee following recommendations from the Clinical Priorities Advisory Group.

National Programmes of Care boards provide assurance that proper process has been followed in the development of proposals for consideration.